68420544 investigational pet tracer iodine 124 evuzamitide from bayer met primary endpoints in phase iii study in patients suspected to have cardiac amyloidosi 004

TAX_DISEASE_HEART_FAILUREGENERAL_GOVERNMENTUSPEC_POLITICS_GENERAL1EPU_POLICY_CONGRESS

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.